tiprankstipranks
SAGE Therapeutics (SAGE)
NASDAQ:SAGE
US Market

SAGE Therapeutics (SAGE) Technical Analysis

Compare
925 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
SAGE Therapeutics’s (SAGE) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting SAGE Therapeutics is a Buy.
SAGE Therapeutics’s (SAGE) 20-Day exponential moving average is 7.09, while SAGE Therapeutics’s (SAGE) share price is $7.15, making it a Buy.
SAGE Therapeutics’s (SAGE) 50-Day exponential moving average is 6.77, while SAGE Therapeutics’s (SAGE) share price is $7.15, making it a Buy.

SAGE Therapeutics (SAGE) Pivot Points

Feb 22, 2025, 03:48 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.82
6.92
6.98
7.08
7.14
7.24
7.30
Fibonacci
6.92
6.98
7.02
7.08
7.14
7.18
7.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SAGE Therapeutics (SAGE) Moving Averages

Feb 22, 2025, 03:48 AM
Period
Simple
Exponential
MA5
7.14Buy
7.14Buy
MA10
7.18Sell
7.16Sell
MA20
7.22Sell
7.09Buy
MA50
6.46Buy
6.77Buy
MA100
6.43Buy
7.10Buy
MA200
8.28Sell
9.33Sell
SAGE Therapeutics’s (SAGE) 10-Day exponential moving average is 7.16, while SAGE Therapeutics’s (SAGE) share price is $7.15, making it a Sell.
SAGE Therapeutics’s (SAGE) 100-Day exponential moving average is 7.10, while SAGE Therapeutics’s (SAGE) share price is $7.15, making it a Buy.
SAGE Therapeutics’s (SAGE) stock price is $7.15 and SAGE Therapeutics’s (SAGE) 50-day simple moving average is 6.46, creating a Buy signal.
SAGE Therapeutics’s (SAGE) stock price is $7.15 and SAGE Therapeutics’s (SAGE) 100-day simple moving average is 6.43, creating a Buy signal.
SAGE Therapeutics’s (SAGE) stock price is $7.15 and SAGE Therapeutics’s (SAGE) 200-day simple moving average is 8.28, creating a Sell signal.

SAGE Therapeutics (SAGE) Technical Indicators

Feb 22, 2025, 03:48 AM
Name
Value
Implied Action
RSI (14)
55.87
Neutral
STOCH (9,6)
31.01
Neutral
STOCHRSI (14)
29.75
Neutral
MACD (12,26)
0.15
Buy
ADX (14)
17.22
Buy
Williams %R
-62.79
Buy
CCI (14)
-67.66
Neutral
ATR (14)
0.25
-
Ultimate Oscillator
52.50
Neutral
ROC
-2.72
Sell
SAGE Therapeutics’s (SAGE) Relative Strength Index (RSI) is 55.87, creating a Neutral signal.
SAGE Therapeutics’s (SAGE) Trend Strength Indicator (ADX) is 17.22, creating a Buy signal.
SAGE Therapeutics’s (SAGE) Commodity Channel Index (CCI) is -67.66, creating a Neutral signal.
SAGE Therapeutics’s (SAGE) Price Rate of Change (ROC) is -2.72, creating a Sell signal.

FAQ

Is SAGE a Buy, Hold, or Sell?
Based on SAGE’s technical indicators, SAGE is a Buy.
    What is SAGE’s RSI (14)?
    SAGE’s RSI (14) is 55.87, which suggests SAGE is a Neutral.
      What is SAGE’s MACD?
      SAGE’s MACD is 0.15, which suggests SAGE is a Buy.
        What is SAGE’s 5-day moving average?
        SAGE’s 5-day moving average is 7.14, which suggests SAGE is a Buy.
          What is SAGE’s 20-day moving average?
          SAGE 20-day moving average is 7.22, which suggests SAGE is a Sell.
            What is SAGE’s 50-day moving average?
            SAGE’s 50-day moving average is 6.46, which suggests SAGE is a Buy.
              What is SAGE’s 200-day moving average?
              SAGE’s 200-day moving average is 8.28, which suggests SAGE is a Sell.
                What is SAGE’s Williams % R (14)?
                SAGE’s Williams % R (14) is -62.79, which suggests SAGE is a Buy.
                  What is SAGE’s CCI (14)?
                  SAGE’s CCI (14) is -67.66, which suggests SAGE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis